期刊
CURRENT TOPICS IN MEDICINAL CHEMISTRY
卷 11, 期 15, 页码 1964-1977出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156802611796391230
关键词
Chemogenomics; proteochemometrics; deorphanization; GPCR; virtual screening; G-protein coupled receptors; orphan receptors; target prediction; mode of action analysis
资金
- Dutch Top Institute Pharma (TI Pharma) [D1-105]
- Novartis Institutes for BioMedical Research
- EPSRC
- BBSRC
- MRC
- Wellcome Trust
- Francis and Augustus Newman Foundation
Chemogenomic approaches, which link ligand chemistry to bioactivity against targets (and, by extension, to phenotypes) are becoming more and more important due to the increasing number of bioactivity data available both in proprietary databases as well as in the public domain. In this article we review chemogenomics approaches applied in four different domains: Firstly, due to the relationship between protein targets from which an approximate relation between their respective bioactive ligands can be inferred, we investigate the extent to which chemogenomics approaches can be applied to receptor deorphanization. In this case it was found that by using knowledge about active compounds of related proteins, in 93% of all cases enrichment better than random could be obtained. Secondly, we analyze different cheminformatics analysis methods with respect to their behavior in chemogenomics studies, such as subgraph mining and Bayesian models. Thirdly, we illustrate how chemogenomics, in its particular flavor of 'proteochemometrics', can be applied to extrapolate bioactivity predictions from given data points to related targets. Finally, we extend the concept of 'chemogenomics' approaches, relating ligand chemistry to bioactivity against related targets, into phenotypic space which then falls into the area of 'chemical genomics' and 'chemical genetics'; given that this is very often the desired endpoint of approaches in not only the pharmaceutical industry, but also in academic probe discovery, this is often the endpoint the experimental scientist is most interested in.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据